Amarin Corporation plc (AMRN) |
0.8786 -0.005 (-0.53%) 04-24 16:00 |
Open: | 0.88 |
High: | 0.889 |
Low: | 0.8655 |
Volume: | 657,214 |
Market Cap: | 359(M) |
PE Ratio: | -5.86 |
Exchange: | NASDAQ Global Market |
Industry: | Biotechnology |
Sector: | Healthcare |
Technical analysis | ||||
sell | buy |
Resistance 2: | 1.11 |
Resistance 1: | 1.00 |
Pivot price: | 0.96 |
Support 1: | 0.83 |
Support 2: | 0.69 |
52w High: | 1.49 |
52w Low: | 0.65 |
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. The company sells its products principally to wholesalers and specialty pharmacy providers. It has a collaboration with Mochida Pharmaceutical Co., Ltd. to develop and commercialize drug products and indications based on the active pharmaceutical ingredient in Vascepa, the omega-3 acid, and eicosapentaenoic acid. The company was formerly known as Ethical Holdings plc and changed its name to Amarin Corporation plc in 1999. Amarin Corporation plc was incorporated in 1989 and is headquartered in Dublin, Ireland.
EPS | -0.150 |
Book Value | 1.350 |
PEG Ratio | -0.16 |
Gross Profit | 0.000 |
Profit Margin (%) | -19.26 |
Operating Margin (%) | -6.17 |
Return on Assets (ttm) | -1.3 |
Return on Equity (ttm) | -10.3 |
Wed, 24 Apr 2024
Amarin (AMRN) to Release Earnings on Wednesday - MarketBeat
Mon, 22 Apr 2024
Amarin Shareholders Show Strong Support at Annual Meeting - TipRanks.com - TipRanks
Tue, 12 Mar 2024
Little Excitement Around Amarin Corporation plc's (NASDAQ:AMRN) Revenues As Shares Take 27% Pounding - Simply Wall St
Sat, 02 Mar 2024
Earnings Update: Amarin Corporation plc (NASDAQ:AMRN) Just Reported And Analysts Are Trimming Their Forecasts - Yahoo Finance
Fri, 01 Mar 2024
Amarin Corporation Plc's New Competition Risk – A Cause for Worry? - TipRanks.com - TipRanks
Thu, 29 Feb 2024
Amarin Corporation plc (AMRN) Q4 2023 Earnings Call Transcript - Seeking Alpha
StockChart iOS |
StoxlineLite iOS |
StoxlineLite iOS |
OptionCalc iOS |
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |